QA: Xencor Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001326732_2026_Xencor_Inc.pdf

Logs

Graph

Absolute values for 0001326732, Xencor Inc

  xvar xval
0 AssetsCurrent 599,821,000
1 IntangibleAssetsNetIncludingGoodwill 8,385,000
2 PropertyPlantAndEquipmentNet 53,308,000
3 remainder_Assets 213,981,000
4 LiabilitiesCurrent 95,907,000
5 LiabilitiesNoncurrent 141,217,000
6 remainder_Liabilities 2,784,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 67,494,146
9 ResearchAndDevelopmentExpense 244,863,981
10 remainder_Expenses 2,200,086
11 remainder_Revenues 121,111,985
12 remainder_NetIncome 18,135,630
13 remainder_ComprehensiveNetIncome 2,272,553
  yvar yval
0 Assets 875,495,000
1 Liabilities 239,908,000
2 Expenses 314,558,213
3 Revenues 121,111,985
4 StockholdersEquity 635,587,000
5 NetIncome -175,310,598
6 ComprehensiveNetIncome -174,174,322
7 BaseVar 785,740,690
8 EconomicCapitalRatiobeforeLimitedLiability 2.17
9 EconomicCapitalRatio 3.14

Edgar->Model Mapping

Feature Distribution

Change over Time